0
USD ▼
EUR USD GBP
+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Mutation Detection Kits in Genome Editing Market by Technology, Detection Method, Application, End User, Distribution Channel, Workflow Stage - Global Forecast to 2030- Product Image
Mutation Detection Kits in Genome Editing Market by Technology, Detection Method, Application, End User, Distribution Channel, Workflow Stage - Global Forecast to 2030- Product Image
Sale

Mutation Detection Kits in Genome Editing Market by Technology, Detection Method, Application, End User, Distribution Channel, Workflow Stage - Global Forecast to 2030

  • PDF Icon

    Report

  • 196 Pages
  • May 2025
  • Region: Global
  • 360iResearch™
  • ID: 5715885
UP TO EUR$697USDGBP OFF until Dec 31st 2025
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.
The Mutation Detection Kits In Genome Editing Market grew from USD 222.74 million in 2024 to USD 259.19 million in 2025. It is expected to continue growing at a CAGR of 15.91%, reaching USD 540.39 million by 2030.

Understanding the Pivotal Role of Mutation Detection Kits

The landscape of genome editing stands at an inflection point, propelled by remarkable advances in CRISPR technology and the growing demand for precision tools that can reliably identify and quantify genetic modifications. With research institutions, clinical laboratories, and biopharmaceutical companies all vying to optimize editing workflows, the role of mutation detection kits has never been more critical. These kits serve as the cornerstone for validating targeted edits, ensuring quality control at the pre-editing stage, and confirming successful edits during post-editing validation. As the complexity of editing platforms grows-encompassing CRISPR systems such as Cas9, Cas12, and Cas13, as well as legacy nucleases like meganucleases, TALENs, and ZFNs-robust detection technologies ranging from digital PCR to high-throughput sequencing have emerged to meet diverse research and diagnostic applications.

Evolving Technologies Redefine Detection Standards

The mutation detection arena has undergone transformative shifts driven by technological convergence and evolving end-user requirements. New high-resolution methods have displaced conventional approaches, accelerating workflows and reducing turnaround times. Advances in sequencing chemistries and bioinformatics algorithms now allow deep interrogation of off-target events, enabling researchers to fine-tune editing parameters in real time. Collaboration between technology developers and contract research organizations has streamlined kit validation and compliance, setting new standards for accuracy and reproducibility. Parallel progress in machine learning-powered data analysis has further enhanced the interpretive power of detection platforms, enabling clinicians and scientists to extract actionable insights from complex datasets. These shifts have collectively elevated expectations for mutation detection, positioning it as an indispensable component of any genome editing pipeline.

Navigating the Cost Implications of U.S. Tariffs

In 2025, the imposition of additional tariffs on critical reagents and instrumentation has significantly altered cost structures across the genome editing supply chain. Imported sequencing consumables and specialized enzymes now carry elevated duties, triggering price adjustments by manufacturers and distributors. This has prompted leading kit providers to reassess their sourcing strategies, exploring localized supply agreements and strategic alliances to mitigate price volatility. End users face the consequential challenge of balancing budget constraints against the imperative for high-fidelity detection. Clinical diagnostic laboratories, in particular, have initiated bulk procurement plans and long-term contracts to lock in favorable pricing, while research institutions are consolidating orders to achieve economies of scale. The cumulative effect of these tariffs underscores the importance of supply chain agility and strategic procurement practices in preserving operational continuity.

Unveiling Multifaceted Segmentation Dynamics

The mutation detection market can be dissected into multiple dimensions that reveal nuanced opportunities and challenges. When assessing technology platforms, CRISPR dominates with its Cas9, Cas12, and Cas13 subtypes, while established nucleases such as meganuclease, TALEN, and ZFN maintain a presence in specialized applications. Detection methods range from high-resolution melt analysis to next-generation sequencing-encompassing targeted, amplicon, and whole genome approaches-as well as PCR techniques that include digital, endpoint, and real-time formats alongside restriction fragment length polymorphism and Sanger sequencing. Application areas span agricultural biotechnology, basic research, clinical diagnostics, drug discovery, and personalized medicine, each demanding tailored performance profiles and regulatory clearances. End users vary from academic and research institutes to clinical diagnostic laboratories, contract research organizations, and pharmaceutical and biotechnology companies, with each segment valuing unique service models and support structures. Distribution channels extend from direct sales and distributor networks to online platforms and original equipment manufacturers. Workflow stages cover pre-editing quality control, post-editing validation, and data analysis, underscoring the need for integrated solutions that seamlessly bridge multiple phases of the editing lifecycle.

Charting Regional Opportunities and Regulatory Landscapes

Regional dynamics in mutation detection reveal a mosaic of demand drivers and regulatory landscapes. In the Americas, substantial public and private investment fuels rapid adoption of cutting-edge kits, particularly within translational research and clinical diagnostics. Collaborative initiatives between academic consortia and industry partners accelerate method standardization and drive competitive pricing. Across Europe, the Middle East, and Africa, evolving regulatory frameworks shape market access, with harmonized guidelines fostering cross-border research collaborations while individual countries refine approval pathways for diagnostic applications. Localized manufacturing hubs are emerging to address supply chain resilience and reduce dependency on imports. The Asia-Pacific region demonstrates robust growth fueled by government-backed precision medicine programs and a burgeoning contract research organization ecosystem. Investments in biotechnology parks and life science clusters have intensified, creating fertile ground for both homegrown innovators and multinational enterprises to expand their footprint.

Key Competitive Trends Shaping Market Leadership

The competitive landscape is defined by both established life science tool providers and emerging specialists. Leading instrumentation firms continue to integrate advanced optics and microfluidics into detection platforms, carving out performance advantages in sensitivity and throughput. At the same time, niche players differentiate through bespoke assay chemistries and cloud-enabled data analysis pipelines that cater to complex editing outcomes. Strategic collaborations, licensing agreements, and acquisitions have become routine as companies seek to bolster their product portfolios and expand geographic reach. Intellectual property remains a key asset, with patent holdings on novel enzyme variants and proprietary algorithms driving valuations and partnership negotiations. To stay ahead, firms must not only invest in R&D but also cultivate global distribution networks and robust technical support services that address the diverse needs of end users.

Actionable Strategies to Strengthen Market Position

Industry leaders should prioritize the development of modular and scalable detection workflows that can adapt to evolving genome editing modalities. Cultivating partnerships with reagent manufacturers and bioinformatics providers will enable seamless end-to-end solutions, enhancing user experience and reducing barriers to adoption. Strategic investments in local manufacturing capabilities can insulate operations from tariff-induced cost pressures and supply disruptions. Embracing open-access data standards and interoperable software frameworks will foster community adoption and streamline validation processes. Organizations should also consider targeted pilot programs with key opinion leaders to generate real-world evidence and expedite regulatory clearances. By combining technical innovation with agile commercial strategies, companies can position themselves as preferred partners in both research and clinical markets.

Ensuring Rigor Through a Comprehensive Methodology

This research draws upon a robust methodology combining primary interviews with industry stakeholders, including senior executives, research scientists, and regulatory experts, alongside comprehensive secondary data analysis. Proprietary databases were examined to map vendor offerings, patent landscapes, and distribution channels. Market structuring leveraged a multi-dimensional segmentation framework encompassing technology, detection method, application, end user, distribution channel, and workflow stage. Regional market sizing and trend analysis incorporated recent regulatory filings, grant awards, and corporate financial disclosures. All qualitative insights were validated through triangulation to ensure accuracy and relevance. The study deliberately refrains from providing specific market estimates or forecasts, focusing instead on delivering strategic intelligence and actionable guidance.

Conclusions on the Future of Mutation Detection Kits

As genome editing continues its rapid advance, the importance of reliable mutation detection cannot be overstated. The convergence of sophisticated enzyme platforms, high-resolution analytical methods, and data-driven insights is redefining what is possible in both research and clinical settings. Nevertheless, market participants must navigate geopolitical headwinds, evolving regulatory standards, and intensifying competition. Success will hinge on the ability to deliver validated, user-friendly solutions backed by strong technical support and strategic supply chain partnerships. By staying attuned to shifting customer priorities and regulatory developments, stakeholders can unlock new growth avenues and solidify their position in this dynamic and transformative market.

Market Segmentation & Coverage

This research report categorizes to forecast the revenues and analyze trends in each of the following sub-segmentations:
  • Technology
    • Cripsr
      • Cas12
      • Cas13
      • Cas9
    • Meaganuclease
    • Talen
    • Zfn
  • Detection Method
    • High Resolution Melt Analysis
    • Ngs
      • Amplicon Sequencing
      • Targeted Sequencing
      • Whole Genome Sequencing
    • Pcr
      • Digital Pcr
      • End Point Pcr
      • Real Time Pcr
    • Restriction Fragment Length Polymorphism
    • Sanger Sequencing
  • Application
    • Agricultural Biotechnology
    • Basic Research
    • Clinical Diagnostics
    • Drug Discovery
    • Personalized Medicine
  • End User
    • Academic And Research Institute
    • Clinical Diagnostic Laboratory
    • Contract Research Organization
    • Pharmaceutical And Biotechnology Company
  • Distribution Channel
    • Direct Sale
    • Distributor
    • Online Distribution
    • Original Equipment Manufacturer
  • Workflow Stage
    • Data Analysis
    • Post Editing Validation
    • Pre Editing Quality Control
This research report categorizes to forecast the revenues and analyze trends in each of the following sub-regions:
  • Americas
    • United States
      • California
      • Texas
      • New York
      • Florida
      • Illinois
      • Pennsylvania
      • Ohio
    • Canada
    • Mexico
    • Brazil
    • Argentina
  • Europe, Middle East & Africa
    • United Kingdom
    • Germany
    • France
    • Russia
    • Italy
    • Spain
    • United Arab Emirates
    • Saudi Arabia
    • South Africa
    • Denmark
    • Netherlands
    • Qatar
    • Finland
    • Sweden
    • Nigeria
    • Egypt
    • Turkey
    • Israel
    • Norway
    • Poland
    • Switzerland
  • Asia-Pacific
    • China
    • India
    • Japan
    • Australia
    • South Korea
    • Indonesia
    • Thailand
    • Philippines
    • Malaysia
    • Singapore
    • Vietnam
    • Taiwan
This research report categorizes to delves into recent significant developments and analyze trends in each of the following companies:
  • Thermo Fisher Scientific Inc.
  • Illumina, Inc.
  • QIAGEN N.V.
  • Agilent Technologies, Inc.
  • F. Hoffmann-La Roche Ltd
  • Promega Corporation
  • New England Biolabs, Inc.
  • Bio-Rad Laboratories, Inc.
  • Merck KGaA
  • Takara Bio Inc.

 

Additional Product Information:

  • Purchase of this report includes 1 year online access with quarterly updates.
  • This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
4.1. Introduction
4.2. Market Sizing & Forecasting
5. Market Dynamics
6. Market Insights
6.1. Porter’s Five Forces Analysis
6.2. PESTLE Analysis
7. Cumulative Impact of United States Tariffs 2025
8. Mutation Detection Kits in Genome Editing Market, by Technology
8.1. Introduction
8.2. Cripsr
8.2.1. Cas12
8.2.2. Cas13
8.2.3. Cas9
8.3. Meaganuclease
8.4. Talen
8.5. Zfn
9. Mutation Detection Kits in Genome Editing Market, by Detection Method
9.1. Introduction
9.2. High Resolution Melt Analysis
9.3. Ngs
9.3.1. Amplicon Sequencing
9.3.2. Targeted Sequencing
9.3.3. Whole Genome Sequencing
9.4. Pcr
9.4.1. Digital Pcr
9.4.2. End Point Pcr
9.4.3. Real Time Pcr
9.5. Restriction Fragment Length Polymorphism
9.6. Sanger Sequencing
10. Mutation Detection Kits in Genome Editing Market, by Application
10.1. Introduction
10.2. Agricultural Biotechnology
10.3. Basic Research
10.4. Clinical Diagnostics
10.5. Drug Discovery
10.6. Personalized Medicine
11. Mutation Detection Kits in Genome Editing Market, by End User
11.1. Introduction
11.2. Academic and Research Institute
11.3. Clinical Diagnostic Laboratory
11.4. Contract Research Organization
11.5. Pharmaceutical and Biotechnology Company
12. Mutation Detection Kits in Genome Editing Market, by Distribution Channel
12.1. Introduction
12.2. Direct Sale
12.3. Distributor
12.4. Online Distribution
12.5. Original Equipment Manufacturer
13. Mutation Detection Kits in Genome Editing Market, by Workflow Stage
13.1. Introduction
13.2. Data Analysis
13.3. Post Editing Validation
13.4. Pre Editing Quality Control
14. Americas Mutation Detection Kits in Genome Editing Market
14.1. Introduction
14.2. United States
14.3. Canada
14.4. Mexico
14.5. Brazil
14.6. Argentina
15. Europe, Middle East & Africa Mutation Detection Kits in Genome Editing Market
15.1. Introduction
15.2. United Kingdom
15.3. Germany
15.4. France
15.5. Russia
15.6. Italy
15.7. Spain
15.8. United Arab Emirates
15.9. Saudi Arabia
15.10. South Africa
15.11. Denmark
15.12. Netherlands
15.13. Qatar
15.14. Finland
15.15. Sweden
15.16. Nigeria
15.17. Egypt
15.18. Turkey
15.19. Israel
15.20. Norway
15.21. Poland
15.22. Switzerland
16. Asia-Pacific Mutation Detection Kits in Genome Editing Market
16.1. Introduction
16.2. China
16.3. India
16.4. Japan
16.5. Australia
16.6. South Korea
16.7. Indonesia
16.8. Thailand
16.9. Philippines
16.10. Malaysia
16.11. Singapore
16.12. Vietnam
16.13. Taiwan
17. Competitive Landscape
17.1. Market Share Analysis, 2024
17.2. FPNV Positioning Matrix, 2024
17.3. Competitive Analysis
17.3.1. Thermo Fisher Scientific Inc.
17.3.2. Illumina, Inc.
17.3.3. QIAGEN N.V.
17.3.4. Agilent Technologies, Inc.
17.3.5. F. Hoffmann-La Roche Ltd
17.3.6. Promega Corporation
17.3.7. New England Biolabs, Inc.
17.3.8. Bio-Rad Laboratories, Inc.
17.3.9. Merck KGaA
17.3.10. Takara Bio Inc.
18. ResearchAI
19. ResearchStatistics
20. ResearchContacts
21. ResearchArticles
22. Appendix
List of Figures
FIGURE 1. MUTATION DETECTION KITS IN GENOME EDITING MARKET MULTI-CURRENCY
FIGURE 2. MUTATION DETECTION KITS IN GENOME EDITING MARKET MULTI-LANGUAGE
FIGURE 3. MUTATION DETECTION KITS IN GENOME EDITING MARKET RESEARCH PROCESS
FIGURE 4. GLOBAL MUTATION DETECTION KITS IN GENOME EDITING MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 5. GLOBAL MUTATION DETECTION KITS IN GENOME EDITING MARKET SIZE, BY REGION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 6. GLOBAL MUTATION DETECTION KITS IN GENOME EDITING MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 7. GLOBAL MUTATION DETECTION KITS IN GENOME EDITING MARKET SIZE, BY TECHNOLOGY, 2024 VS 2030 (%)
FIGURE 8. GLOBAL MUTATION DETECTION KITS IN GENOME EDITING MARKET SIZE, BY TECHNOLOGY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 9. GLOBAL MUTATION DETECTION KITS IN GENOME EDITING MARKET SIZE, BY DETECTION METHOD, 2024 VS 2030 (%)
FIGURE 10. GLOBAL MUTATION DETECTION KITS IN GENOME EDITING MARKET SIZE, BY DETECTION METHOD, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 11. GLOBAL MUTATION DETECTION KITS IN GENOME EDITING MARKET SIZE, BY APPLICATION, 2024 VS 2030 (%)
FIGURE 12. GLOBAL MUTATION DETECTION KITS IN GENOME EDITING MARKET SIZE, BY APPLICATION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 13. GLOBAL MUTATION DETECTION KITS IN GENOME EDITING MARKET SIZE, BY END USER, 2024 VS 2030 (%)
FIGURE 14. GLOBAL MUTATION DETECTION KITS IN GENOME EDITING MARKET SIZE, BY END USER, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 15. GLOBAL MUTATION DETECTION KITS IN GENOME EDITING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024 VS 2030 (%)
FIGURE 16. GLOBAL MUTATION DETECTION KITS IN GENOME EDITING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 17. GLOBAL MUTATION DETECTION KITS IN GENOME EDITING MARKET SIZE, BY WORKFLOW STAGE, 2024 VS 2030 (%)
FIGURE 18. GLOBAL MUTATION DETECTION KITS IN GENOME EDITING MARKET SIZE, BY WORKFLOW STAGE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 19. AMERICAS MUTATION DETECTION KITS IN GENOME EDITING MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 20. AMERICAS MUTATION DETECTION KITS IN GENOME EDITING MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 21. UNITED STATES MUTATION DETECTION KITS IN GENOME EDITING MARKET SIZE, BY STATE, 2024 VS 2030 (%)
FIGURE 22. UNITED STATES MUTATION DETECTION KITS IN GENOME EDITING MARKET SIZE, BY STATE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 23. EUROPE, MIDDLE EAST & AFRICA MUTATION DETECTION KITS IN GENOME EDITING MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 24. EUROPE, MIDDLE EAST & AFRICA MUTATION DETECTION KITS IN GENOME EDITING MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 25. ASIA-PACIFIC MUTATION DETECTION KITS IN GENOME EDITING MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 26. ASIA-PACIFIC MUTATION DETECTION KITS IN GENOME EDITING MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 27. MUTATION DETECTION KITS IN GENOME EDITING MARKET SHARE, BY KEY PLAYER, 2024
FIGURE 28. MUTATION DETECTION KITS IN GENOME EDITING MARKET, FPNV POSITIONING MATRIX, 2024
List of Tables
TABLE 1. MUTATION DETECTION KITS IN GENOME EDITING MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
TABLE 3. GLOBAL MUTATION DETECTION KITS IN GENOME EDITING MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 4. GLOBAL MUTATION DETECTION KITS IN GENOME EDITING MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
TABLE 5. GLOBAL MUTATION DETECTION KITS IN GENOME EDITING MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 6. GLOBAL MUTATION DETECTION KITS IN GENOME EDITING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 7. GLOBAL MUTATION DETECTION KITS IN GENOME EDITING MARKET SIZE, BY CRIPSR, BY REGION, 2018-2030 (USD MILLION)
TABLE 8. GLOBAL MUTATION DETECTION KITS IN GENOME EDITING MARKET SIZE, BY CAS12, BY REGION, 2018-2030 (USD MILLION)
TABLE 9. GLOBAL MUTATION DETECTION KITS IN GENOME EDITING MARKET SIZE, BY CAS13, BY REGION, 2018-2030 (USD MILLION)
TABLE 10. GLOBAL MUTATION DETECTION KITS IN GENOME EDITING MARKET SIZE, BY CAS9, BY REGION, 2018-2030 (USD MILLION)
TABLE 11. GLOBAL MUTATION DETECTION KITS IN GENOME EDITING MARKET SIZE, BY CRIPSR, 2018-2030 (USD MILLION)
TABLE 12. GLOBAL MUTATION DETECTION KITS IN GENOME EDITING MARKET SIZE, BY MEAGANUCLEASE, BY REGION, 2018-2030 (USD MILLION)
TABLE 13. GLOBAL MUTATION DETECTION KITS IN GENOME EDITING MARKET SIZE, BY TALEN, BY REGION, 2018-2030 (USD MILLION)
TABLE 14. GLOBAL MUTATION DETECTION KITS IN GENOME EDITING MARKET SIZE, BY ZFN, BY REGION, 2018-2030 (USD MILLION)
TABLE 15. GLOBAL MUTATION DETECTION KITS IN GENOME EDITING MARKET SIZE, BY DETECTION METHOD, 2018-2030 (USD MILLION)
TABLE 16. GLOBAL MUTATION DETECTION KITS IN GENOME EDITING MARKET SIZE, BY HIGH RESOLUTION MELT ANALYSIS, BY REGION, 2018-2030 (USD MILLION)
TABLE 17. GLOBAL MUTATION DETECTION KITS IN GENOME EDITING MARKET SIZE, BY NGS, BY REGION, 2018-2030 (USD MILLION)
TABLE 18. GLOBAL MUTATION DETECTION KITS IN GENOME EDITING MARKET SIZE, BY AMPLICON SEQUENCING, BY REGION, 2018-2030 (USD MILLION)
TABLE 19. GLOBAL MUTATION DETECTION KITS IN GENOME EDITING MARKET SIZE, BY TARGETED SEQUENCING, BY REGION, 2018-2030 (USD MILLION)
TABLE 20. GLOBAL MUTATION DETECTION KITS IN GENOME EDITING MARKET SIZE, BY WHOLE GENOME SEQUENCING, BY REGION, 2018-2030 (USD MILLION)
TABLE 21. GLOBAL MUTATION DETECTION KITS IN GENOME EDITING MARKET SIZE, BY NGS, 2018-2030 (USD MILLION)
TABLE 22. GLOBAL MUTATION DETECTION KITS IN GENOME EDITING MARKET SIZE, BY PCR, BY REGION, 2018-2030 (USD MILLION)
TABLE 23. GLOBAL MUTATION DETECTION KITS IN GENOME EDITING MARKET SIZE, BY DIGITAL PCR, BY REGION, 2018-2030 (USD MILLION)
TABLE 24. GLOBAL MUTATION DETECTION KITS IN GENOME EDITING MARKET SIZE, BY END POINT PCR, BY REGION, 2018-2030 (USD MILLION)
TABLE 25. GLOBAL MUTATION DETECTION KITS IN GENOME EDITING MARKET SIZE, BY REAL TIME PCR, BY REGION, 2018-2030 (USD MILLION)
TABLE 26. GLOBAL MUTATION DETECTION KITS IN GENOME EDITING MARKET SIZE, BY PCR, 2018-2030 (USD MILLION)
TABLE 27. GLOBAL MUTATION DETECTION KITS IN GENOME EDITING MARKET SIZE, BY RESTRICTION FRAGMENT LENGTH POLYMORPHISM, BY REGION, 2018-2030 (USD MILLION)
TABLE 28. GLOBAL MUTATION DETECTION KITS IN GENOME EDITING MARKET SIZE, BY SANGER SEQUENCING, BY REGION, 2018-2030 (USD MILLION)
TABLE 29. GLOBAL MUTATION DETECTION KITS IN GENOME EDITING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 30. GLOBAL MUTATION DETECTION KITS IN GENOME EDITING MARKET SIZE, BY AGRICULTURAL BIOTECHNOLOGY, BY REGION, 2018-2030 (USD MILLION)
TABLE 31. GLOBAL MUTATION DETECTION KITS IN GENOME EDITING MARKET SIZE, BY BASIC RESEARCH, BY REGION, 2018-2030 (USD MILLION)
TABLE 32. GLOBAL MUTATION DETECTION KITS IN GENOME EDITING MARKET SIZE, BY CLINICAL DIAGNOSTICS, BY REGION, 2018-2030 (USD MILLION)
TABLE 33. GLOBAL MUTATION DETECTION KITS IN GENOME EDITING MARKET SIZE, BY DRUG DISCOVERY, BY REGION, 2018-2030 (USD MILLION)
TABLE 34. GLOBAL MUTATION DETECTION KITS IN GENOME EDITING MARKET SIZE, BY PERSONALIZED MEDICINE, BY REGION, 2018-2030 (USD MILLION)
TABLE 35. GLOBAL MUTATION DETECTION KITS IN GENOME EDITING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 36. GLOBAL MUTATION DETECTION KITS IN GENOME EDITING MARKET SIZE, BY ACADEMIC AND RESEARCH INSTITUTE, BY REGION, 2018-2030 (USD MILLION)
TABLE 37. GLOBAL MUTATION DETECTION KITS IN GENOME EDITING MARKET SIZE, BY CLINICAL DIAGNOSTIC LABORATORY, BY REGION, 2018-2030 (USD MILLION)
TABLE 38. GLOBAL MUTATION DETECTION KITS IN GENOME EDITING MARKET SIZE, BY CONTRACT RESEARCH ORGANIZATION, BY REGION, 2018-2030 (USD MILLION)
TABLE 39. GLOBAL MUTATION DETECTION KITS IN GENOME EDITING MARKET SIZE, BY PHARMACEUTICAL AND BIOTECHNOLOGY COMPANY, BY REGION, 2018-2030 (USD MILLION)
TABLE 40. GLOBAL MUTATION DETECTION KITS IN GENOME EDITING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 41. GLOBAL MUTATION DETECTION KITS IN GENOME EDITING MARKET SIZE, BY DIRECT SALE, BY REGION, 2018-2030 (USD MILLION)
TABLE 42. GLOBAL MUTATION DETECTION KITS IN GENOME EDITING MARKET SIZE, BY DISTRIBUTOR, BY REGION, 2018-2030 (USD MILLION)
TABLE 43. GLOBAL MUTATION DETECTION KITS IN GENOME EDITING MARKET SIZE, BY ONLINE DISTRIBUTION, BY REGION, 2018-2030 (USD MILLION)
TABLE 44. GLOBAL MUTATION DETECTION KITS IN GENOME EDITING MARKET SIZE, BY ORIGINAL EQUIPMENT MANUFACTURER, BY REGION, 2018-2030 (USD MILLION)
TABLE 45. GLOBAL MUTATION DETECTION KITS IN GENOME EDITING MARKET SIZE, BY WORKFLOW STAGE, 2018-2030 (USD MILLION)
TABLE 46. GLOBAL MUTATION DETECTION KITS IN GENOME EDITING MARKET SIZE, BY DATA ANALYSIS, BY REGION, 2018-2030 (USD MILLION)
TABLE 47. GLOBAL MUTATION DETECTION KITS IN GENOME EDITING MARKET SIZE, BY POST EDITING VALIDATION, BY REGION, 2018-2030 (USD MILLION)
TABLE 48. GLOBAL MUTATION DETECTION KITS IN GENOME EDITING MARKET SIZE, BY PRE EDITING QUALITY CONTROL, BY REGION, 2018-2030 (USD MILLION)
TABLE 49. AMERICAS MUTATION DETECTION KITS IN GENOME EDITING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 50. AMERICAS MUTATION DETECTION KITS IN GENOME EDITING MARKET SIZE, BY CRIPSR, 2018-2030 (USD MILLION)
TABLE 51. AMERICAS MUTATION DETECTION KITS IN GENOME EDITING MARKET SIZE, BY DETECTION METHOD, 2018-2030 (USD MILLION)
TABLE 52. AMERICAS MUTATION DETECTION KITS IN GENOME EDITING MARKET SIZE, BY NGS, 2018-2030 (USD MILLION)
TABLE 53. AMERICAS MUTATION DETECTION KITS IN GENOME EDITING MARKET SIZE, BY PCR, 2018-2030 (USD MILLION)
TABLE 54. AMERICAS MUTATION DETECTION KITS IN GENOME EDITING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 55. AMERICAS MUTATION DETECTION KITS IN GENOME EDITING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 56. AMERICAS MUTATION DETECTION KITS IN GENOME EDITING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 57. AMERICAS MUTATION DETECTION KITS IN GENOME EDITING MARKET SIZE, BY WORKFLOW STAGE, 2018-2030 (USD MILLION)
TABLE 58. AMERICAS MUTATION DETECTION KITS IN GENOME EDITING MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 59. UNITED STATES MUTATION DETECTION KITS IN GENOME EDITING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 60. UNITED STATES MUTATION DETECTION KITS IN GENOME EDITING MARKET SIZE, BY CRIPSR, 2018-2030 (USD MILLION)
TABLE 61. UNITED STATES MUTATION DETECTION KITS IN GENOME EDITING MARKET SIZE, BY DETECTION METHOD, 2018-2030 (USD MILLION)
TABLE 62. UNITED STATES MUTATION DETECTION KITS IN GENOME EDITING MARKET SIZE, BY NGS, 2018-2030 (USD MILLION)
TABLE 63. UNITED STATES MUTATION DETECTION KITS IN GENOME EDITING MARKET SIZE, BY PCR, 2018-2030 (USD MILLION)
TABLE 64. UNITED STATES MUTATION DETECTION KITS IN GENOME EDITING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 65. UNITED STATES MUTATION DETECTION KITS IN GENOME EDITING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 66. UNITED STATES MUTATION DETECTION KITS IN GENOME EDITING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 67. UNITED STATES MUTATION DETECTION KITS IN GENOME EDITING MARKET SIZE, BY WORKFLOW STAGE, 2018-2030 (USD MILLION)
TABLE 68. UNITED STATES MUTATION DETECTION KITS IN GENOME EDITING MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
TABLE 69. CANADA MUTATION DETECTION KITS IN GENOME EDITING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 70. CANADA MUTATION DETECTION KITS IN GENOME EDITING MARKET SIZE, BY CRIPSR, 2018-2030 (USD MILLION)
TABLE 71. CANADA MUTATION DETECTION KITS IN GENOME EDITING MARKET SIZE, BY DETECTION METHOD, 2018-2030 (USD MILLION)
TABLE 72. CANADA MUTATION DETECTION KITS IN GENOME EDITING MARKET SIZE, BY NGS, 2018-2030 (USD MILLION)
TABLE 73. CANADA MUTATION DETECTION KITS IN GENOME EDITING MARKET SIZE, BY PCR, 2018-2030 (USD MILLION)
TABLE 74. CANADA MUTATION DETECTION KITS IN GENOME EDITING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 75. CANADA MUTATION DETECTION KITS IN GENOME EDITING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 76. CANADA MUTATION DETECTION KITS IN GENOME EDITING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 77. CANADA MUTATION DETECTION KITS IN GENOME EDITING MARKET SIZE, BY WORKFLOW STAGE, 2018-2030 (USD MILLION)
TABLE 78. MEXICO MUTATION DETECTION KITS IN GENOME EDITING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 79. MEXICO MUTATION DETECTION KITS IN GENOME EDITING MARKET SIZE, BY CRIPSR, 2018-2030 (USD MILLION)
TABLE 80. MEXICO MUTATION DETECTION KITS IN GENOME EDITING MARKET SIZE, BY DETECTION METHOD, 2018-2030 (USD MILLION)
TABLE 81. MEXICO MUTATION DETECTION KITS IN GENOME EDITING MARKET SIZE, BY NGS, 2018-2030 (USD MILLION)
TABLE 82. MEXICO MUTATION DETECTION KITS IN GENOME EDITING MARKET SIZE, BY PCR, 2018-2030 (USD MILLION)
TABLE 83. MEXICO MUTATION DETECTION KITS IN GENOME EDITING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 84. MEXICO MUTATION DETECTION KITS IN GENOME EDITING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 85. MEXICO MUTATION DETECTION KITS IN GENOME EDITING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 86. MEXICO MUTATION DETECTION KITS IN GENOME EDITING MARKET SIZE, BY WORKFLOW STAGE, 2018-2030 (USD MILLION)
TABLE 87. BRAZIL MUTATION DETECTION KITS IN GENOME EDITING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 88. BRAZIL MUTATION DETECTION KITS IN GENOME EDITING MARKET SIZE, BY CRIPSR, 2018-2030 (USD MILLION)
TABLE 89. BRAZIL MUTATION DETECTION KITS IN GENOME EDITING MARKET SIZE, BY DETECTION METHOD, 2018-2030 (USD MILLION)
TABLE 90. BRAZIL MUTATION DETECTION KITS IN GENOME EDITING MARKET SIZE, BY NGS, 2018-2030 (USD MILLION)
TABLE 91. BRAZIL MUTATION DETECTION KITS IN GENOME EDITING MARKET SIZE, BY PCR, 2018-2030 (USD MILLION)
TABLE 92. BRAZIL MUTATION DETECTION KITS IN GENOME EDITING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 93. BRAZIL MUTATION DETECTION KITS IN GENOME EDITING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 94. BRAZIL MUTATION DETECTION KITS IN GENOME EDITING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 95. BRAZIL MUTATION DETECTION KITS IN GENOME EDITING MARKET SIZE, BY WORKFLOW STAGE, 2018-2030 (USD MILLION)
TABLE 96. ARGENTINA MUTATION DETECTION KITS IN GENOME EDITING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 97. ARGENTINA MUTATION DETECTION KITS IN GENOME EDITING MARKET SIZE, BY CRIPSR, 2018-2030 (USD MILLION)
TABLE 98. ARGENTINA MUTATION DETECTION KITS IN GENOME EDITING MARKET SIZE, BY DETECTION METHOD, 2018-2030 (USD MILLION)
TABLE 99. ARGENTINA MUTATION DETECTION KITS IN GENOME EDITING MARKET SIZE, BY NGS, 2018-2030 (USD MILLION)
TABLE 100. ARGENTINA MUTATION DETECTION KITS IN GENOME EDITING MARKET SIZE, BY PCR, 2018-2030 (USD MILLION)
TABLE 101. ARGENTINA MUTATION DETECTION KITS IN GENOME EDITING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 102. ARGENTINA MUTATION DETECTION KITS IN GENOME EDITING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 103. ARGENTINA MUTATION DETECTION KITS IN GENOME EDITING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 104. ARGENTINA MUTATION DETECTION KITS IN GENOME EDITING MARKET SIZE, BY WORKFLOW STAGE, 2018-2030 (USD MILLION)
TABLE 105. EUROPE, MIDDLE EAST & AFRICA MUTATION DETECTION KITS IN GENOME EDITING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 106. EUROPE, MIDDLE EAST & AFRICA MUTATION DETECTION KITS IN GENOME EDITING MARKET SIZE, BY CRIPSR, 2018-2030 (USD MILLION)
TABLE 107. EUROPE, MIDDLE EAST & AFRICA MUTATION DETECTION KITS IN GENOME EDITING MARKET SIZE, BY DETECTION METHOD, 2018-2030 (USD MILLION)
TABLE 108. EUROPE, MIDDLE EAST & AFRICA MUTATION DETECTION KITS IN GENOME EDITING MARKET SIZE, BY NGS, 2018-2030 (USD MILLION)
TABLE 109. EUROPE, MIDDLE EAST & AFRICA MUTATION DETECTION KITS IN GENOME EDITING MARKET SIZE, BY PCR, 2018-2030 (USD MILLION)
TABLE 110. EUROPE, MIDDLE EAST & AFRICA MUTATION DETECTION KITS IN GENOME EDITING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 111. EUROPE, MIDDLE EAST & AFRICA MUTATION DETECTION KITS IN GENOME EDITING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 112. EUROPE, MIDDLE EAST & AFRICA MUTATION DETECTION KITS IN GENOME EDITING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 113. EUROPE, MIDDLE EAST & AFRICA MUTATION DETECTION KITS IN GENOME EDITING MARKET SIZE, BY WORKFLOW STAGE, 2018-2030 (USD MILLION)
TABLE 114. EUROPE, MIDDLE EAST & AFRICA MUTATION DETECTION KITS IN GENOME EDITING MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 115. UNITED KINGDOM MUTATION DETECTION KITS IN GENOME EDITING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 116. UNITED KINGDOM MUTATION DETECTION KITS IN GENOME EDITING MARKET SIZE, BY CRIPSR, 2018-2030 (USD MILLION)
TABLE 117. UNITED KINGDOM MUTATION DETECTION KITS IN GENOME EDITING MARKET SIZE, BY DETECTION METHOD, 2018-2030 (USD MILLION)
TABLE 118. UNITED KINGDOM MUTATION DETECTION KITS IN GENOME EDITING MARKET SIZE, BY NGS, 2018-2030 (USD MILLION)
TABLE 119. UNITED KINGDOM MUTATION DETECTION KITS IN GENOME EDITING MARKET SIZE, BY PCR, 2018-2030 (USD MILLION)
TABLE 120. UNITED KINGDOM MUTATION DETECTION KITS IN GENOME EDITING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 121. UNITED KINGDOM MUTATION DETECTION KITS IN GENOME EDITING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 122. UNITED KINGDOM MUTATION DETECTION KITS IN GENOME EDITING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 123. UNITED KINGDOM MUTATION DETECTION KITS IN GENOME EDITING MARKET SIZE, BY WORKFLOW STAGE, 2018-2030 (USD MILLION)
TABLE 124. GERMANY MUTATION DETECTION KITS IN GENOME EDITING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 125. GERMANY MUTATION DETECTION KITS IN GENOME EDITING MARKET SIZE, BY CRIPSR, 2018-2030 (USD MILLION)
TABLE 126. GERMANY MUTATION DETECTION KITS IN GENOME EDITING MARKET SIZE, BY DETECTION METHOD, 2018-2030 (USD MILLION)
TABLE 127. GERMANY MUTATION DETECTION KITS IN GENOME EDITING MARKET SIZE, BY NGS, 2018-2030 (USD MILLION)
TABLE 128. GERMANY MUTATION DETECTION KITS IN GENOME EDITING MARKET SIZE, BY PCR, 2018-2030 (USD MILLION)
TABLE 129. GERMANY MUTATION DETECTION KITS IN GENOME EDITING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 130. GERMANY MUTATION DETECTION KITS IN GENOME EDITING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 131. GERMANY MUTATION DETECTION KITS IN GENOME EDITING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 132. GERMANY MUTATION DETECTION KITS IN GENOME EDITING MARKET SIZE, BY WORKFLOW STAGE, 2018-2030 (USD MILLION)
TABLE 133. FRANCE MUTATION DETECTION KITS IN GENOME EDITING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 134. FRANCE MUTATION DETECTION KITS IN GENOME EDITING MARKET SIZE, BY CRIPSR, 2018-2030 (USD MILLION)
TABLE 135. FRANCE MUTATION DETECTION KITS IN GENOME EDITING MARKET SIZE, BY DETECTION METHOD, 2018-2030 (USD MILLION)
TABLE 136. FRANCE MUTATION DETECTION KITS IN GENOME EDITING MARKET SIZE, BY NGS, 2018-2030 (USD MILLION)
TABLE 137. FRANCE MUTATION DETECTION KITS IN GENOME EDITING MARKET SIZE, BY PCR, 2018-2030 (USD MILLION)
TABLE 138. FRANCE MUTATION DETECTION KITS IN GENOME EDITING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 139. FRANCE MUTATION DETECTION KITS IN GENOME EDITING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 140. FRANCE MUTATION DETECTION KITS IN GENOME EDITING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 141. FRANCE MUTATION DETECTION KITS IN GENOME EDITING MARKET SIZE, BY WORKFLOW STAGE, 2018-2030 (USD MILLION)
TABLE 142. RUSSIA MUTATION DETECTION KITS IN GENOME EDITING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 143. RUSSIA MUTATION DETECTION KITS IN GENOME EDITING MARKET SIZE, BY CRIPSR, 2018-2030 (USD MILLION)
TABLE 144. RUSSIA MUTATION DETECTION KITS IN GENOME EDITING MARKET SIZE, BY DETECTION METHOD, 2018-2030 (USD MILLION)
TABLE 145. RUSSIA MUTATION DETECTION KITS IN GENOME EDITING MARKET SIZE, BY NGS, 2018-2030 (USD MILLION)
TABLE 146. RUSSIA MUTATION DETECTION KITS IN GENOME EDITING MARKET SIZE, BY PCR, 2018-2030 (USD MILLION)
TABLE 147. RUSSIA MUTATION DETECTION KITS IN GENOME EDITING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 148. RUSSIA MUTATION DETECTION KITS IN GENOME EDITING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 149. RUSSIA MUTATION DETECTION KITS IN GENOME EDITING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 150. RUSSIA MUTATION DETECTION KITS IN GENOME EDITING MARKET SIZE, BY WORKFLOW STAGE, 2018-2030 (USD MILLION)
TABLE 151. ITALY MUTATION DETECTION KITS IN GENOME EDITING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 152. ITALY MUTATION DETECTION KITS IN GENOME EDITING MARKET SIZE, BY CRIPSR, 2018-2030 (USD MILLION)
TABLE 153. ITALY MUTATION DETECTION KITS IN GENOME EDITING MARKET SIZE, BY DETECTION METHOD, 2018-2030 (USD MILLION)
TABLE 154. ITALY MUTATION DETECTION KITS IN GENOME EDITING MARKET SIZE, BY NGS, 2018-2030 (USD MILLION)
TABLE 155. ITALY MUTATION DETECTION KITS IN GENOME EDITING MARKET SIZE, BY PCR, 2018-2030 (USD MILLION)
TABLE 156. ITALY MUTATION DETECTION KITS IN GENOME EDITING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 157. ITALY MUTATION DETECTION KITS IN GENOME EDITING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 158. ITALY MUTATION DETECTION KITS IN GENOME EDITING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 159. ITALY MUTATION DETECTION KITS IN GENOME EDITING MARKET SIZE, BY WORKFLOW STAGE, 2018-2030 (USD MILLION)
TABLE 160. SPAIN MUTATION DETECTION KITS IN GENOME EDITING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 161. SPAIN MUTATION DETECTION KITS IN GENOME EDITING MARKET SIZE, BY CRIPSR, 2018-2030 (USD MILLION)
TABLE 162. SPAIN MUTATION DETECTION KITS IN GENOME EDITING MARKET SIZE, BY DETECTION METHOD, 2018-2030 (USD MILLION)
TABLE 163. SPAIN MUTATION DETECTION KITS IN GENOME EDITING MARKET SIZE, BY NGS, 2018-2030 (USD MILLION)
TABLE 164. SPAIN MUTATION DETECTION KITS IN GENOME EDITING MARKET SIZE, BY PCR, 2018-2030 (USD MILLION)
TABLE 165. SPAIN MUTATION DETECTION KITS IN GENOME EDITING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 166. SPAIN MUTATION DETECTION KITS IN GENOME EDITING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 167. SPAIN MUTATION DETECTION KITS IN GENOME EDITING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 168. SPAIN MUTATION DETECTION KITS IN GENOME EDITING MARKET SIZE, BY WORKFLOW STAGE, 2018-2030 (USD MILLION)
TABLE 169. UNITED ARAB EMIRATES MUTATION DETECTION KITS IN GENOME EDITING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 170. UNITED ARAB EMIRATES MUTATION DETECTION KITS IN GENOME EDITING MARKET SIZE, BY CRIPSR, 2018-2030 (USD MILLION)
TABLE 171. UNITED ARAB EMIRATES MUTATION DETECTION KITS IN GENOME EDITING MARKET SIZE, BY DETECTION METHOD, 2018-2030 (USD MILLION)
TABLE 172. UNITED ARAB EMIRATES MUTATION DETECTION KITS IN GENOME EDITING MARKET SIZE, BY NGS, 2018-2030 (USD MILLION)
TABLE 173. UNITED ARAB EMIRATES MUTATION DETECTION KITS IN GENOME EDITING MARKET SIZE, BY PCR, 2018-2030 (USD MILLION)
TABLE 174. UNITED ARAB EMIRATES MUTATION DETECTION KITS IN GENOME EDITING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 175. UNITED ARAB EMIRATES MUTATION DETECTION KITS IN GENOME EDITING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 176. UNITED ARAB EMIRATES MUTATION DETECTION KITS IN GENOME EDITING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 177. UNITED ARAB EMIRATES MUTATION DETECTION KITS IN GENOME EDITING MARKET SIZE, BY WORKFLOW STAGE, 2018-2030 (USD MILLION)
TABLE 178. SAUDI ARABIA MUTATION DETECTION KITS IN GENOME EDITING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 179. SAUDI ARABIA MUTATION DETECTION KITS IN GENOME EDITING MARKET SIZE, BY CRIPSR, 2018-2030 (USD MILLION)
TABLE 180. SAUDI ARABIA MUTATION DETECTION KITS IN GENOME EDITING MARKET SIZE, BY DETECTION METHOD, 2018-2030 (USD MILLION)
TABLE 181. SAUDI ARABIA MUTATION DETECTION KITS IN GENOME EDITING MARKET SIZE, BY NGS, 2018-2030 (USD MILLION)
TABLE 182. SAUDI ARABIA MUTATION DETECTION KITS IN GENOME EDITING MARKET SIZE, BY PCR, 2018-2030 (USD MILLION)
TABLE 183. SAUDI ARABIA MUTATION DETECTION KITS IN GENOME EDITING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 184. SAUDI ARABIA MUTATION DETECTION KITS IN GENOME EDITING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 185. SAUDI ARABIA MUTATION DETECTION KITS IN GENOME EDITING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 186. SAUDI ARABIA MUTATION DETECTION KITS IN GENOME EDITING MARKET SIZE, BY WORKFLOW STAGE, 2018-2030 (USD MILLION)
TABLE 187. SOUTH AFRICA MUTATION DETECTION KITS IN GENOME EDITING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 188. SOUTH AFRICA MUTATION DETECTION KITS IN GENOME EDITING MARKET SIZE, BY CRIPSR, 2018-2030 (USD MILLION)
TABLE 189. SOUTH AFRICA MUTATION DETECTION KITS IN GENOME EDITING MARKET SIZE, BY DETECTION METHOD, 2018-2030 (USD MILLION)
TABLE 190. SOUTH AFRICA MUTATION DETECTION KITS IN GENOME EDITING MARKET SIZE, BY NGS, 2018-2030 (USD MILLION)
TABLE 191. SOUTH AFRICA MUTATION DETECTION KITS IN GENOME EDITING MARKET SIZE, BY PCR, 2018-2030 (USD MILLION)
TABLE 192. SOUTH AFRICA MUTATION DETECTION KITS IN GENOME EDITING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 193. SOUTH AFRICA MUTATION DETECTION KITS IN GENOME EDITING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 194. SOUTH AFRICA MUTATION DETECTION KITS IN GENOME EDITING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 195. SOUTH AFRICA MUTATION DETECTION KITS IN GENOME EDITING MARKET SIZE, BY WORKFLOW STAGE, 2018-2030 (USD MILLION)
TABLE 196. DENMARK MUTATION DETECTION KITS IN GENOME EDITING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 197. DENMARK MUTATION DETECTION KITS IN GENOME EDITING MARKET SIZE, BY CRIPSR, 2018-2030 (USD MILLION)
TABLE 198. DENMARK MUTATION DETECTION KITS IN GENOME EDITING MARKET SIZE, BY DETECTION METHOD, 2018-2030 (USD MILLION)
TABLE 199. DENMARK MUTATION DETECTION KITS IN GENOME EDITING MARKET SIZE, BY NGS, 2018-2030 (USD MILLION)
TABLE 200. DENMARK MUTATION DETECTION KITS IN GENOME EDITING MARKET SIZE, BY PCR, 2018-2030 (USD MILLION)
TABLE 201. DENMARK MUTATION DETECTION KITS IN GENOME EDITING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 202. DENMARK MUTATION DETECTION KITS IN GENOME EDITING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 203. DENMARK MUTATION DETECTION KITS IN GENOME EDITING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 204. DENMARK MUTATION DETECTION KITS IN GENOME EDITING MARKET SIZE, BY WORKFLOW STAGE, 2018-2030 (USD MILLION)
TABLE 205. NETHERLANDS MUTATION DETECTION KITS IN GENOME EDITING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 206. NETHERLANDS MUTATION DETECTION KITS IN GENOME EDITING MARKET SIZE, BY CRIPSR, 2018-2030 (USD MILLION)
TABLE 207. NETHERLANDS MUTATION DETECTION KITS IN GENOME EDITING MARKET SIZE, BY DETECTION METHOD, 2018-2030 (USD MILLION)
TABLE 208. NETHERLANDS MUTATION DETECTION KITS IN GENOME EDITING MARKET SIZE, BY NGS, 2018-2030 (USD MILLION)
TABLE 209. NETHERLANDS MUTATION DETECTION KITS IN GENOME EDITING MARKET SIZE, BY PCR, 2018-2030 (USD MILLION)
TABLE 210. NETHERLANDS MUTATION DETECTION KITS IN GENOME EDITING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 211. NETHERLANDS MUTATION DETECTION KITS IN GENOME EDITING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 212. NETHERLANDS MUTATION DETECTION KITS IN GENOME EDITING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 213. NETHERLANDS MUTATION DETECTION KITS IN GENOME EDITING MARKET SIZE, BY WORKFLOW STAGE, 2018-2030 (USD MILLION)
TABLE 214. QATAR MUTATION DETECTION KITS IN GENOME EDITING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 215. QATAR MUTATION DETECTION KITS IN GENOME EDITING MARKET SIZE, BY CRIPSR, 2018-2030 (USD MILLION)
TABLE 216. QATAR MUTATION DETECTION KITS IN GENOME EDITING MARKET SIZE, BY DETECTION METHOD, 2018-2030 (USD MILLION)
TABLE 217. QATAR MUTATION DETECTION KITS IN GENOME EDITING MARKET SIZE, BY NGS, 2018-2030 (USD MILLION)
TABLE 218. QATAR MUTATION DETECTION KITS IN GENOME EDITING MARKET SIZE, BY PCR, 2018-2030 (USD MILLION)
TABLE 219. QATAR MUTATION DETECTION KITS IN GENOME EDITING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 220. QATAR MUTATION DETECTION KITS IN GENOME EDITING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 221. QATAR MUTATION DETECTION KITS IN GENOME EDITING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 222. QATAR MUTATION DETECTION KITS IN GENOME EDITING MARKET SIZE, BY WORKFLOW STAGE, 2018-2030 (USD MILLION)
TABLE 223. FINLAND MUTATION DETECTION KITS IN GENOME EDITING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 224. FINLAND MUTATION DETECTION KITS IN GENOME EDITING MARKET SIZE, BY CRIPSR, 2018-2030 (USD MILLION)
TABLE 225. FINLAND MUTATION DETECTION KITS IN GENOME EDITING MARKET SIZE, BY DETECTION METHOD, 2018-2030 (USD MILLION)
TABLE 226. FINLAND MUTATION DETECTION KITS IN GENOME EDITING MARKET SIZE, BY NGS, 2018-2030 (USD MILLION)
TABLE 227. FINLAND MUTATION DETECTION KITS IN GENOME EDITING MARKET SIZE, BY PCR, 2018-2030 (USD MILLION)
TABLE 228. FINLAND MUTATION DETECTION KITS IN GENOME EDITING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 229. FINLAND MUTATION DETECTION KITS IN GENOME EDITING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 230. FINLAND MUTATION DETECTION KITS IN GENOME EDITING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 231. FINLAND MUTATION DETECTION KITS IN GENOME EDITING MARKET SIZE, BY WORKFLOW STAGE, 2018-2030 (USD MILLION)
TABLE 232. SWEDEN MUTATION DETECTION KITS IN GENOME EDITING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 233. SWEDEN MUTATION DETECTION KITS IN GENOME EDITING MARKET SIZE, BY CRIPSR, 2018-2030 (USD MILLION)
TABLE 234. SWEDEN MUTATION DETECTION KITS IN GENOME EDITING MARKET SIZE, BY DETECTION METHOD, 2018-2030 (USD MILLION)
TABLE 235. SWEDEN MUTATION DETECTION KITS IN GENOME EDITING MARKET SIZE, BY NGS, 2018-2030 (USD MILLION)
TABLE 236. SWEDEN MUTATION DETECTION KITS IN GENOME EDITING MARKET SIZE, BY PCR, 2018-2030 (USD MILLION)
TABLE 237. SWEDEN MUTATION DETECTION KITS IN GENOME EDITING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 238. SWEDEN MUTATION DETECTION KITS IN GENOME EDITING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 239. SWEDEN MUTATION DETECTION KITS IN GENOME EDITING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 240. SWEDEN MUTATION DETECTION KITS IN GENOME EDITING MARKET SIZE, BY WORKFLOW STAGE, 2018-2030 (USD MILLION)
TABLE 241. NIGERIA MUTATION DETECTION KITS IN GENOME EDITING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 242. NIGERIA MUTATION DETECTION KITS IN GENOME EDITING MARKET SIZE, BY CRIPSR, 2018-2030 (USD MILLION)
TABLE 243. NIGERIA MUTATION DETECTION KITS IN GENOME EDITING MARKET SIZE, BY DETECTION METHOD, 2018-2030 (USD MILLION)
TABLE 244. NIGERIA MUTATION DETECTION KITS IN GENOME EDITING MARKET SIZE, BY NGS, 2018-2030 (USD MILLION)
TABLE 245. NIGERIA MUTATION DETECTION KITS IN GENOME EDITING MARKET SIZE, BY PCR, 2018-2030 (USD MILLION)
TABLE 246. NIGERIA MUTATION DETECTION KITS IN GENOME EDITING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 247. NIGERIA MUTATION DETECTION KITS IN GENOME EDITING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 248. NIGERIA MUTATION DETECTION KITS IN GENOME EDITING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 249. NIGERIA MUTATION DETECTION KITS IN GENOME EDITING MARKET SIZE, BY WORKFLOW STAGE, 2018-2030 (USD MILLION)
TABLE 250. EGYPT MUTATION DETECTION KITS IN GENOME EDITING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 251. EGYPT MUTATION DETECTION KITS IN GENOME EDITING MARKET SIZE, BY CRIPSR, 2018-2030 (USD MILLION)
TABLE 252. EGYPT MUTATION DETECTION KITS IN GENOME EDITING MARKET SIZE, BY DETECTION METHOD, 2018-2030 (USD MILLION)
TABLE 253. EGYPT MUTATION DETECTION KITS IN GENOME EDITING MARKET SIZE, BY NGS, 2018-2030 (USD MILLION)
TABLE 254. EGYPT MUTATION DETECTION KITS IN GENOME EDITING MARKET SIZE, BY PCR, 2018-2030 (USD MILLION)
TABLE 255. EGYPT MUTATION DETECTION KITS IN GENOME EDITING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 256. EGYPT MUTATION DETECTION KITS IN GENOME EDITING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 257. EGYPT MUTATION DETECTION KITS IN GENOME EDITING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 258. EGYPT MUTATION DETECTION KITS IN GENOME EDITING MARKET SIZE, BY WORKFLOW STAGE, 2018-2030 (USD MILLION)
TABLE 259. TURKEY MUTATION DETECTION KITS IN GENOME EDITING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 260. TURKEY MUTATION DETECTION KITS IN GENOME EDITING MARKET SIZE, BY CRIPSR, 2018-2030 (USD MILLION)
TABLE 261. TURKEY MUTATION DETECTION KITS IN GENOME EDITING MARKET SIZE, BY DETECTION METHOD, 2018-2030 (USD MILLION)
TABLE 262. TURKEY MUTATION DETECTION KITS IN GENOME EDITING MARKET SIZE, BY NGS, 2018-2030 (USD MILLION)
TABLE 263. TURKEY MUTATION DETECTION KITS IN GENOME EDITING MARKET SIZE, BY PCR, 2018-2030 (USD MILLION)
TABLE 264. TURKEY MUTATION DETECTION KITS IN GENOME EDITING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 265. TURKEY MUTATION DETECTION KITS IN GENOME EDITING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 266. TURKEY MUTATION DETECTION KITS IN GENOME EDITING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 267. TURKEY MUTATION DETECTION KITS IN GENOME EDITING MARKET SIZE, BY WORKFLOW STAGE, 2018-2030 (USD MILLION)
TABLE 268. ISRAEL MUTATION DETECTION KITS IN GENOME EDITING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 269. ISRAEL MUTATION DETECTION KITS IN GENOME EDITING MARKET SIZE, BY CRIPSR, 2018-2030 (USD MILLION)
TABLE 270. ISRAEL MUTATION DETECTION KITS IN GENOME EDITING MARKET SIZE, BY DETECTION METHOD, 2018-2030 (USD MILLION)
TABLE 271. ISRAEL MUTATION DETECTION KITS IN GENOME EDITING MARKET SIZE, BY NGS, 2018-2030 (USD MILLION)
TABLE 272. ISRAEL MUTATION DETECTION KITS IN GENOME EDITING MARKET SIZE, BY PCR, 2018-2030 (USD MILLION)
TABLE 273. ISRAEL MUTATION DETECTION KITS IN GENOME EDITING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 274. ISRAEL MUTATION DETECTION KITS IN GENOME EDITING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 275. ISRAEL MUTATION DETECTION KITS IN GENOME EDITING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 276. ISRAEL MUTATION DETECTION KITS IN GENOME EDITING MARKET SIZE, BY WORKFLOW STAGE, 2018-2030 (USD MILLION)
TABLE 277. NORWAY MUTATION DETECTION KITS IN GENOME EDITING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 278. NORWAY MUTATION DETECTION KITS IN GENOME EDITING MARKET SIZE, BY CRIPSR, 2018-2030 (USD MILLION)
TABLE 279. NORWAY MUTATION DETECTION KITS IN GENOME EDITING MARKET SIZE, BY DETECTION METHOD, 2018-2030 (USD MILLION)
TABLE 280. NORWAY MUTATION DETECTION KITS IN GENOME EDITING MARKET SIZE, BY NGS, 2018-2030 (USD MILLION)
TABLE 281. NORWAY MUTATION DETECTION KITS IN GENOME EDITING MARKET SIZE, BY PCR, 2018-2030 (USD MILLION)
TABLE 282. NORWAY MUTATION DETECTION KITS IN GENOME EDITING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 283. NORWAY MUTATION DETECTION KITS IN GENOME EDITING MARKET SIZE, BY

Companies Mentioned

The companies profiled in this Mutation Detection Kits In Genome Editing market report include:
  • Thermo Fisher Scientific Inc.
  • Illumina, Inc.
  • QIAGEN N.V.
  • Agilent Technologies, Inc.
  • F. Hoffmann-La Roche Ltd
  • Promega Corporation
  • New England Biolabs, Inc.
  • Bio-Rad Laboratories, Inc.
  • Merck KGaA
  • Takara Bio Inc.

Methodology

Methodology DOWNLOAD NOW

Table Information

Report AttributeDetails
No. of Pages196
PublishedMay 2025
Forecast Period2025 - 2030
Estimated Market Value ( USD ) in 2025 $ 259.19 Million
Forecasted Market Value ( USD ) by 2030 $ 540.39 Million
Compound Annual Growth Rate15.9%
Regions CoveredGlobal
No. of Companies Mentioned11

Related Topics

Related Reports

Genome Editing Market - Global Industry Size, Share, Trends Opportunity, and Forecast, 2020-2030F - Product Image

Genome Editing Market - Global Industry Size, Share, Trends Opportunity, and Forecast, 2020-2030F

  • Report
  • 185 Pages
  • Global
From
EUR$4,500USDGBP
Genome Editing / Genome Engineering - Global Strategic Business Report - Product Image

Genome Editing / Genome Engineering - Global Strategic Business Report

  • Report
  • 187 Pages
  • Global
From
EUR$5,850USDGBP
Gene Editing Market by Product (Kits, Reagents, Libraries, Software), Services (GRNA Synthesis & Vector Construction), Technique (Knock-Out, Knock-in), Technology (CRISPR, ZFN, TALEN), Application (Genome Editing, Drug Discovery) - Global Forecast to 2029 - Product Image

Gene Editing Market by Product (Kits, Reagents, Libraries, Software), Services (GRNA Synthesis & Vector Construction), Technique (Knock-Out, Knock-in), Technology (CRISPR, ZFN, TALEN), Application (Genome Editing, Drug Discovery) - Global Forecast to 2029

  • Report
  • 498 Pages
  • Global
From
EUR$4,950USDGBP
Genome Editing/Genome Engineering Market Report 2025 - Product Image

Genome Editing/Genome Engineering Market Report 2025

  • Report
  • 200 Pages
  • Global
From
EUR$4,490USDGBP
Global Whole Genome and Exome Sequencing Market: Focus on Product, Workflow, Application, End User, Region, and Competitive Landscape - Analysis and Forecast, 2024-2033 - Product Image

Global Whole Genome and Exome Sequencing Market: Focus on Product, Workflow, Application, End User, Region, and Competitive Landscape - Analysis and Forecast, 2024-2033

  • Report
  • 106 Pages
  • Global
From
EUR$5,500USDGBP

About the Mutation Detection Kit Market

The Mutation Detection Kit market is a subset of the genomics industry, which focuses on the study of genetic material. These kits are used to detect genetic mutations, which can be used to diagnose and treat genetic diseases. The kits are also used in research to identify genetic markers associated with certain diseases. The kits are designed to detect single nucleotide polymorphisms (SNPs), small insertions and deletions, and other genetic variations. The Mutation Detection Kit market is highly competitive, with a variety of companies offering different products. Some of the major players in the market include Thermo Fisher Scientific, Illumina, Agilent Technologies, QIAGEN, and Bio-Rad Laboratories. Show Less Read more

Copyright © 2002-2025 Research and Markets. All Rights Reserved.
This website uses cookies to ensure you get the best experience. Learn more